Asset Details
Do you wish to reserve the book?
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study
Do you wish to request the book?
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study
2001
Overview
In Germany, clomethiazole (CLO) and benzodiazepines are predominantly used as therapeutic agents in the treatment of the alcohol withdrawal syndrome (AWS). These agents have disadvantages such as sedation, risk of respiratory insufficiency, and cardiovascular complications as well as addictive potential. Alternatively, it could be demonstrated that both tiapride (TIA) and carbamazepine (CBZ) are efficient in the treatment of AWS with less toxicity. However, they seem to be less effective in AWS than CLO as single agents. But no systematic comparison of the combination of TIA and CBZ against an established therapeutic standard can be found in the literature. Therefore, we compared the combination of TIA and CBZ with CLO in two open exploratory studies with matched samples. Outcome parameters were heart rate, blood pressure, complications, withdrawal symptoms (CIWA-Ar scale), and general clinical state (CGI scale). A retrospective evaluation of medical records (30 TIA+CBZ, 30 CLO) was followed by an open prospective study (40 TIA+CBZ, 40 CLO). Both studies revealed similar efficacy in terms of psychopathologic and vegetative symptoms. Vegetative recovery seems to be faster with TIA+CBZ. Results of this exploratory study have to be confirmed by a controlled double-blind study with severity of AWS as an experimental factor.
Publisher
Springer Nature B.V
Subject
/ Alcohol
/ Alcohol Withdrawal Delirium - complications
/ Alcohol Withdrawal Delirium - drug therapy
/ Alcohol Withdrawal Seizures - etiology
/ Anticonvulsants - adverse effects
/ Anticonvulsants - therapeutic use
/ Antipsychotic Agents - adverse effects
/ Antipsychotic Agents - therapeutic use
/ Carbamazepine - adverse effects
/ Carbamazepine - therapeutic use
/ Chlormethiazole - adverse effects
/ Chlormethiazole - therapeutic use
/ Female
/ Humans
/ Male
/ Tiapamil Hydrochloride - adverse effects
